✦ LIBER ✦

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

✍ Scribed by Guilherme Rabinowits; Robert I. Haddad

Book ID: 119339292
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 177 KB
Volume: 48
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2012.06.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of resistance to EGFR inhibit

Mechanisms of resistance to EGFR inhibitors in head and neck cancer

✍ Jonathan B. Cooper; Ezra Eddy Wyssam Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositol‐3‐kinase/v‐AKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression

Preclinical modeling of EGFR inhibitor r

Preclinical modeling of EGFR inhibitor resistance in head and neck cancer

✍ Quesnelle, Kelly M.; Wheeler, Sarah E.; Ratay, Mary K.; Grandis, Jennifer R. 📂 Article 📅 2012 🏛 Landes Bioscience 🌐 English ⚖ 904 KB

Novel targets in HPV-negative head and n

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

✍ Burtness, Barbara; Bauman, Julie E; Galloway, Thomas 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 964 KB

Resistance to EGFR kinase inhibitor PD15

Resistance to EGFR kinase inhibitor PD158780 in head and neck cancer cell lines

✍ Mark James Jameson; Andrew D. Beckler; Christopher Y. Thomas; Michael J. Weber; 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 35 KB

IGF-1R-Mediated Resistance to EGFR Kinas

IGF-1R-Mediated Resistance to EGFR Kinase Inhibitor PD158780 in Head and Neck Cancer Cells

✍ Mark James Jameson; Andrew D. Beckler; Lisa B. Sandstrom; Christopher Y. Thomas; 📂 Article 📅 2005 🏛 SAGE Publications 🌐 English ⚖ 48 KB

Beyond Cetuximab for Head and Neck Cance

Beyond Cetuximab for Head and Neck Cancer: Dual Target Antibody Blockade of EGFR and HER3 Enhances Radiosensitivity and Overcomes Acquired Resistance to EGFR Inhibitors

✍ P.M. Harari; S. Huang; C. Li; M.X. Sliwkowski 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB